The only reason I know of is the sell down by a major shareholder, which is over now, but of course one doesn't know what one doesn't know.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025